(Q71517643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

M Segelmark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

A N Elzouki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J Wieslander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S Eriksson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

844-850

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1995.360

19 October 2019

exact match

0 references

cites work

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

How are antineutrophil cytoplasmic autoantibodies detected?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Monoclonal antibody specific for the mutant PiZ alpha 1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Prognostic factors in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Rapidly progressive glomerulonephritis: what should be first-line therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.360

7 January 2021

Identifiers

DOI

10.1038/KI.1995.360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7474674%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference